Strategic Growth Planetary is rapidly expanding its fermentation platform and licensing model, backed by a $20.4M Series A and credit facilities, signaling active investment in scale manufacturing capabilities and licensing partnerships that present opportunities for technology licensing, co-development, and supply agreements.

BioBlocks Licensed The core BioBlocks fermentation technology is licensed to partners for sustainable bio-based products at commercial scale, offering a clear entry point for OEMs, ingredient manufacturers, and food producers seeking to accelerate circular bioeconomy initiatives.

Product Portfolio Planetary is expanding from bio-based ingredients into additional bio-based products and finishes, including mycoprotein-based protein formats, enabling cross-sell opportunities with existing agriculture collaborators and animal/plant-based product lines.

Geographic Footprint With facilities in Switzerland and recent asset acquisitions in Europe (Spain) and Western Europe expansion, there are tangible opportunities for regional partnerships, technology deployment, and supply chain collaboration across European markets.

Customer & Channel Momentum Recent launches such as mycoprotein chicken filet in 242 Aldi stores and partnerships following the Libre Foods acquisition highlight readiness to engage major retail, foodservice, and industrial clients, presenting sales avenues in private label, co-branding, and licensing deals.